NCT07539441 2026-04-20
A Study of Mirdametinib in People With Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Phase 1/2 Recruiting
Memorial Sloan Kettering Cancer Center
Johns Hopkins University
University of Alabama at Birmingham
SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc.